Celebrity Inventors
Actor Marlon Brando has four patents, all named "Drumhead tensioning device and method."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7251082 | Photochromic/vitroceramic window assembly A photochromic/vitroceramic window assembly that restores some of the natural illumination and warm blue-green colors normally excluded from the interior of an enclosed space after blocking at least a portion of infrared and/or UV light, comprising: a) ... | 07/31/2007 |
| 7244027 | Perimeter A perimeter for examining a visual field condition of an examinee's eye, includes: a target presenting unit a response unit brain activity detecting unit which detects an activity condition of a visual cortex of the examinee; and an operation unit which determines i... | 07/17/2007 |
| 7245436 | Illumination device and projector An illumination device includes a light source, a first lens array having a plurality of first small lenses, a second lens array having a plurality of second small lenses corresponding to the plurality of first small lenses, and a superimposing lens. The plurality o... | 07/17/2007 |
| 7224533 | Optically retro-reflecting sphere An optically retro-reflecting sphere includes an inner sphere and an outer concentric spherical shell, and can be coupled to a reflective surface. Light entering the optically retro-reflecting sphere from an incident direction is reflected by the sphere generally to... | 05/29/2007 |
| 7224501 | Light-emitting device and apparatus having the same A light-emitting device is disclosed which allows efficient irradiation of light from a plurality of light sources to achieve a predetermined light emission characteristic and has a small size. The light-emitting device has an optical member which includes a first r... | 05/29/2007 |
| 7209301 | Optical lens Optical elements are provided. An optical element is formed by injecting resin material into a mold through a gate in a first direction. The optical element includes a main body, a flange surrounding and connecting the main body, and a curved depression formed betwe... | 04/24/2007 |
| 7209302 | Hinge with a positioning and limiting assembly A hinge with a positioning and limiting assembly is mounted on an electronic device with a camera and has a stationary bracket, a pivot cylinder, a stationary positioning ring and a rotating positioning ring. The stationary bracket is attached to the electronic devi... | 04/24/2007 |
| 6300373 | Antiproliferative and neurotrophic molecules Neurotrophic and antiproliferative compounds related to the antiepileptic drug valproate are provided. These compounds are useful for promoting neuronal function as in neurodegenerative disorders and for treating neoplastic disease.... | 10/09/2001 |
| 6049012 | Catalyst and process for the production of alkyl tert alkyl ether from hydrocarbon feedstocks with high levels of sulfur A catalyst for production of alkyl tert alkyl ether from sulfur contaminated feedstock includes an ion exchange resin; a palladium first metal phase supported on the resin; and a sulfur inhibiting second metal phase supported on the resin for inhibiting s... | 04/11/2000 |
| 6046233 | Agent for treating cor pulmonale The present invention relates to an agent for treating cor pulmonale containing as an active ingredient a prostaglandin I2 derivative represented by the following formula, or a pharmacologically acceptable salt thereof. The agent exhibits excel... | 04/04/2000 |
| 6037502 | Etherification process This invention provides an improved etherification process that reduces the amount of acidic-ion-exchange-resin catalyst that is deactivated by nitriles. This process uses a water phase to remove nitriles from a hydrocarbon phase followed by an alcohol ph... | 03/14/2000 |
| 6030955 | Methods of affecting intracellular phosphorylation of tyrosine using phosphorothioate oligonucleotides, and antiangiogenic and antiproliferative uses thereof The present invention provides methods of stimulating or inhibiting intracellular phosphorylation of tyrosine by a heparin-binding receptor which comprises contacting a cell having on its surface the heparin-binding receptor with a phosphorothioate oligon... | 02/29/2000 |
| 6017929 | Cholinesterase activator The invention relates to a cholinesterase activator comprising, as an active ingredient, a compound represented by the following general formula (I): ##STR1## wherein A means a group such as a phenyl group or indanyl group, B denotes a group suc... | 01/25/2000 |
| 5969192 | Process for preparing hydrogen-terminated polyoxyperfluoroalkanes A process for preparing hydrogen-terminated polyoxyperfluoroalkanes having molecular weight lower than 1800, by decarboxylation of the corresponding polyoxyperfluoroalkanes having one or two end groups selected form --OCF2 COOZ, --OCF2 | 10/19/1999 |
| 5939407 | Method of protecting against neuron loss The present invention pertains to a method of protecting against neuron loss in a subject by administering a compound that protects against neuron loss by acting through a vitamin D receptor. Some of these compounds may prevent or retard neuron loss by re... | 08/17/1999 |
| 5932623 | Process for the production of fruit polyphenols from unripe rosaceae fruit The present invention provides a fruit polyphenol obtained by subjecting unripe fruits of Rosaceae to pressing and/or extraction and then purifying the resulting juice or extract. The present invention further provides an antioxidant, a hypotensive agent,... | 08/03/1999 |
| 5917053 | Indole-2,3-dione-3-oxime derivatives, their preparation and use The present patent application discloses compounds having the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein R1, X and R5 have the meanings set further in the specification. A is a ring of five to seven atoms ... | 06/29/1999 |
| 5907051 | Catalyst and method for producing carbonic diesters A method of producing a carbonic diester involves allowing an alcohol to react with carbon monoxide and oxygen in the presence of a supported catalyst wherein the support is an activated carbon obtained from a vegetable or polymeric raw material, a suppor... | 05/25/1999 |
| 5879877 | Use of arabinogalactan in a sperm wash product A sperm solution including arabinogalactan is provided which is useful for separating the motile sperm, to produce sperm samples which are suitable for use in a variety of diagnostic and research applications. In one embodiment, the solution includes an e... | 03/09/1999 |
| 5880298 | Process for oligomerization of polyunsaturated acids and esters, products obtained and use thereof For the oligomerization of a fatty ester or fatty acid containing conjugated double bonds, the reaction uses a catalyst consisting of an activated earth, e.g., montmorillonite, at a temperature of from 100°-180° C., preferably from 130°-160° C. The ... | 03/09/1999 |
| 5869672 | Huperzine A and analogs thereof The present invention relates to a method for the synthesis of certain bridged fused ring pyridines. Such bridged fused ring pyridines can be converted to huperzine A and analogs of huperzine A. The present invention also covers such bridged fused ring py... | 02/09/1999 |
| 5869539 | Emulsions of perfluoro compounds as solvents for nitric oxide (NO) The present invention involves perfluoro compound emulsions including nitric oxide, their preparation and their use. These emulsions provide a new source of nitric oxide. Such nitric oxide-containing emulsions may be used for the administration of nitric ... | 02/09/1999 |
| 5863912 | Method of treatment of hormone-unresponsive metastiatic prostate cancer Prostate cancer particularly hormone-unresponsive metastatic prostate cancer, is treated by cyclophosphamide or other normally substantially inactive agent. Potentiation of the anti-cancer activity and amelioration of cyclophosphamide-associated toxicity ... | 01/26/1999 |
| 5859048 | Pharmaceutics for mucosal administration In pharmaceutics for mucosal administration containing pharmacologically active peptides or proteins and tolmetin or salts thereof exhibited very excellent effect as mucosal absorption enhancers. Furthermore, when the pharmaceutics for mucosal administration a... | 01/12/1999 |
| 5856574 | Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them Ortho-substituted benzoylguanidines of the formula I ##STR1## in which R(2) and R(3) have the meanings given in the... | 01/05/1999 |
| 5856585 | Process of catalytic partial oxidation of natural gas in order to obtain synthesis gas and formaldehyde Process of catalytic partial oxidation of natural gas in order to obtain synthesis gas and formaldehyde, integrated with processes of hydrogenation of the resulting CO, such as Fischer-Tropsch and methanol syntheses. Such an oxidation is carried out by me... | 01/05/1999 |
| 5853607 | CVD processing chamber A process chamber is disclosed which provides a 360° circular gas/vacuum distribution over a substrate being processed. The substrate being processed is supported on a heated and optionally cooled pedestal assembly. The substrate faces a one-piece gas di... | 12/29/1998 |
| 5852044 | Use of NK1 receptor antagonists for preparing cardio-regulatory drugs The invention relates to the use of NK1 receptor antagonists for the preparation of drugs with a cardioregulatory action, intended in particular for controlling heart rate disorders and cardiac dysrhythtmia.... | 12/22/1998 |
| 5852016 | Quinoxaline derivatives useful in therapy Compounds of formula (I), wherein A represents N or CH; R1 and R2 independently represent C1-4 alkyl, halo or CF3 ; R3 represents C1-4 alkyl (optionally substituted), C3-7 cycloalkyl,... | 12/22/1998 |
| 5849943 | Stilbene derivatives useful as cyclooxygenase-2 inhibitors The invention encompasses novel compounds of Formula Iuseful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceuticalcompositions and methods for treatment of cyclooxygenase-2 mediated dis... | 12/15/1998 |
| 5846928 | Method for treating cancer patients A new immunotherapy to cancer patients is provided. In the therapy, lymphocytes collected from a patient by leukopheresis are treated with interferon- in vitro for a short period of term and then returned to the patient intravenously. According to ... | 12/08/1998 |
| 5847188 | Carbonate compounds, non-aqueous electrolytic solutions and batteries comprising non-aqueous electrolytic solutions A novel carbonate compound represented by the general formula I!: R1 CH2 O--CO--OCH2 R2 I! wherein R1 represents a hydrogen atom, an alkyl group or an alkyl group substituted with one or mo... | 12/08/1998 |
| 5847224 | Method for improving the color of MTBE, ETBE and TAME A process for improving the color of oxygenates, such as MTBE, ETBE and TAME, which utilizes a hydrogenation treater in the presence of a catalyst, containing at least one noble metal, along with a circulation of hydrogen to remove the color. The process ... | 12/08/1998 |
| 5844115 | Alkoxylation process Active hydrogen containing organic compounds, for example alcohols, thiols, phenols, thiophenols, carboxylic acids, amides and amines, are alkoxylated, for example, ethoxylated, using catalysts comprising a salt of a Group IIa or Group Ia element and an o... | 12/01/1998 |
| 5840722 | Use of carboxylic acid derivatives as drugs A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I ##STR1##... | 11/24/1998 |
| 5837688 | Use of thrombolytic reagents for prevention of vascular disease The present invention relates to the administration of thrombolytic reagents such as tissue plasminogen activator (t-PA), streptokinase and/or urokinase, over prolonged periods of time for prevention of vascular disease such as cerebral vascular thrombosi... | 11/17/1998 |
| 5833954 | Anti-carious chewing gums, candies, gels, toothpastes and dentifrices The invention relates to anticarious delivery vehicles, specifically chewing gums, candies, confectioneries, toothpastes, dentifrices and gels. The invention specifically provides chewing gums, candies, confectioneries, toothpastes, dentifrices and gels c... | 11/10/1998 |
| 5833955 | Diagnostic tests to assess a persons oral malodor capacity and potential for developing periodontitis Oral malodor and periodontitis are common problems affecting a large percentage of the population. The present invention provides a method of assessing an individual's oral malodor producing capacity and potential for developing periodontitis. In particul... | 11/10/1998 |
| 5827856 | Method of treating insulin resistance The present invention provides a novel method for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.... | 10/27/1998 |
| 5817887 | Color-photographic recording material A color-photographic recording material is described which contains a magenta coupler and, as stabilizer, at least one compound of the formula ##STR1## where the radicals are as defined in the specification.... | 10/06/1998 |
